| Partners In Internal Medicine Pllc | |
|
2200 Green Rd Suite B Ann Arbor MI 48105 | |
| (734) 994-7446 | |
| (734) 623-8590 |
| Full Name | Partners In Internal Medicine Pllc |
|---|---|
| Speciality | Internal Medicine |
| Location | 2200 Green Rd, Ann Arbor, Michigan |
| Authorized Official Name and Position | Michelle Hankins (CREDENTIALING) |
| Authorized Official Contact | 7349947446 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Partners In Internal Medicine Pllc 2200 Green Rd Suite B Ann Arbor MI 48105 Ph: (734) 994-7446 | Partners In Internal Medicine Pllc 2200 Green Rd Suite B Ann Arbor MI 48105 Ph: (734) 994-7446 |
| NPI Number | 1780625145 |
|---|---|
| Provider Enumeration Date | 06/09/2006 |
| Last Update Date | 11/02/2023 |
| Medicare PECOS PAC ID | 6103806245 |
|---|---|
| Medicare Enrollment ID | O20040721000304 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780625145 | NPI | - | NPPES |
| 4301075355 | Other | MI | LICENSE (EJS) |
| 4301065397 | Other | MI | LICENSE (PES) |
| 4301069903 | Other | MI | LICENSE (SH) |
| 4301063025 | Other | MI | LICENSE (PRP) |
| 4301095466 | Other | MI | LICENSE (DRW) |
| 4301081318 | Other | MI | LICENSE (BG) |
| 4301043873 | Other | MI | LICENSE (MLG) |
| 4301049857 | Other | MI | LICENSE (MO) |
| 4704243632 | Other | MI | LICENSE (LMC) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (Michigan) | Primary |
| Provider Name | Lisa M Cogswell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366698789 PECOS PAC ID: 7416018270 Enrollment ID: I20081211000578 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Eric J Straka |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1336147735 PECOS PAC ID: 7719030634 Enrollment ID: I20091007000336 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Mark Oberdoerster |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932197423 PECOS PAC ID: 9133199888 Enrollment ID: I20091007000471 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Martha Leigh Gray |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801892294 PECOS PAC ID: 9032189782 Enrollment ID: I20091008000216 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Sara Hashemian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1427054006 PECOS PAC ID: 9638222557 Enrollment ID: I20091008000341 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Peter R Paul |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1407853617 PECOS PAC ID: 2365595287 Enrollment ID: I20091008000358 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Pamela Shore |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1144283243 PECOS PAC ID: 2769565597 Enrollment ID: I20091202000302 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | David R Weidendorf |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1497088876 PECOS PAC ID: 4688821739 Enrollment ID: I20120824000796 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
| Provider Name | Elissa S Gaies |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386008233 PECOS PAC ID: 2264728377 Enrollment ID: I20190930002220 |
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
News Archive
So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth.
Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that clinical data for its lead drug candidate, ANG1005, for the treatment of brain cancers, as well as data showing how compounds from Angiochem's Engineered Peptide Compounds (EPiC) platform are capable of crossing the blood-brain barrier will be highlighted at the Society for Neuroscience Annual Meeting in Chicago on October 17-21, 2009.
Breathe Technologies, Inc., a developer and manufacturer of medical technologies for patients with respiratory insufficiency and neuromuscular diseases, announced today that the U.S. Food and Drug Administration has granted 510(k) clearance for its critical care Breathe Technologies Life2000 Ventilation System, which is intended to provide continuous or intermittent ventilatory support for the care of individuals who require mechanical ventilation.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
› Verified 2 days ago
Dr. Chris Popp, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 107 Aprill Dr Ste 5, Ann Arbor, MI 48103 Phone: 734-212-6668 Fax: 734-212-6891 | |
Regents Of The University Of Michigan Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dennis K Chernin Md Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2345 S Huron Pkwy, Ann Arbor, MI 48104 Phone: 734-973-3030 Fax: 734-973-3057 | |
South Arbor Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 250 W Eisenhower Pkwy, Suite 190, Ann Arbor, MI 48103 Phone: 734-707-7075 Fax: 734-707-4975 | |
Healthcare Professionals Of Ann Arbor Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3063 Oak Valley Dr, Ann Arbor, MI 48103 Phone: 734-492-0040 | |
Michigan Visiting Physician P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2900 Golfside Ste #9, Ann Arbor, MI 48108 Phone: 734-572-1666 | |
Advance Care Visiting Physicians Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3550 Burbank Dr, Ann Arbor, MI 48105 Phone: 734-451-0600 Fax: 734-451-0603 |